Suppr超能文献

HLArestrictor——一种用于预测患者特异性 HLA 限制元件和肽内最优表位的工具。

HLArestrictor--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides.

机构信息

Center for Biological Sequence Analysis, DTU Systems Biology, Building 208, Technical University of Denmark, DK-2800, Lyngby, Denmark.

出版信息

Immunogenetics. 2011 Jan;63(1):43-55. doi: 10.1007/s00251-010-0493-5. Epub 2010 Nov 16.

Abstract

Traditionally, T cell epitope discovery requires considerable amounts of tedious, slow, and costly experimental work. During the last decade, prediction tools have emerged as essential tools allowing researchers to select a manageable list of epitope candidates to test from a larger peptide, protein, or even proteome. However, no current tools address the complexity caused by the highly polymorphic nature of the restricting HLA molecules, which effectively individualizes T cell responses. To fill this gap, we here present an easy-to-use prediction tool named HLArestrictor ( http://www.cbs.dtu.dk/services/HLArestrictor ), which is based on the highly versatile and accurate NetMHCpan predictor, which here has been optimized for the identification of both the MHC restriction element and the corresponding minimal epitope of a T cell response in a given individual. As input, it requires high-resolution (i.e., 4-digit) HLA typing of the individual. HLArestrictor then predicts all 8-11mer peptide binders within one or more larger peptides and provides an overview of the predicted HLA restrictions and minimal epitopes. The method was tested on a large dataset of HIV IFNγ ELIspot peptide responses and was shown to identify HLA restrictions and minimal epitopes for about 90% of the positive peptide/patient pairs while rejecting more than 95% of the negative peptide-HLA pairs. Furthermore, for 18 peptide/HLA tetramer validated responses, HLArestrictor in all cases predicted both the HLA restriction element and minimal epitope. Thus, HLArestrictor should be a valuable tool in any T cell epitope discovery process aimed at identifying new epitopes from infectious diseases and other disease models.

摘要

传统上,T 细胞表位发现需要大量繁琐、缓慢和昂贵的实验工作。在过去的十年中,预测工具已经成为必不可少的工具,允许研究人员从更大的肽、蛋白质甚至蛋白质组中选择可管理的候选表位列表进行测试。然而,目前没有工具可以解决限制 HLA 分子高度多态性引起的复杂性,这些分子有效地使 T 细胞反应个体化。为了填补这一空白,我们在这里介绍了一种易于使用的预测工具,名为 HLArestrictor(http://www.cbs.dtu.dk/services/HLArestrictor),它基于高度通用和准确的 NetMHCpan 预测器,该预测器在这里针对识别给定个体中的 MHC 限制元件和相应的 T 细胞反应最小表位进行了优化。作为输入,它需要个体的高分辨率(即 4 位数字)HLA 分型。HLArestrictor 然后预测一个或多个较大肽内的所有 8-11 mer 肽结合物,并提供预测的 HLA 限制和最小表位概述。该方法在大量 HIV IFNγ ELIspot 肽反应数据集上进行了测试,结果表明它可以识别大约 90%的阳性肽/患者对的 HLA 限制和最小表位,同时拒绝超过 95%的阴性肽-HLA 对。此外,对于 18 个肽/HLA 四聚体验证的反应,HLArestrictor 在所有情况下都预测了 HLA 限制元件和最小表位。因此,HLArestrictor 应该是任何旨在从传染病和其他疾病模型中识别新表位的 T 细胞表位发现过程中的有价值工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验